Med School Research Scientist Timsy Uppal and Engineering post-doctoral researcher Bhaskar Vadlamani testing the SARS-CoV-2 nanosensor.
University of Nevada, Reno engineers and virologists team up for novel approach
Rapid detection of the SARS-CoV-2 virus, in about 30 seconds following the test, has had successful preliminary results in Mano Misra’s lab at the University of Nevada, Reno. The test uses a nanotube-based electrochemical biosensor, a similar technology that Misra has used in the past for detecting tuberculosis and colorectal cancer as well as detection of biomarkers for food safety.
Professor Misra, in the University’s College of Engineering Chemical and Materials Department, has been working on nano-sensors for 10 years. He has expertise in detecting a specific biomarker in tuberculosis patients’ breath using a metal functionalized nano sensor.
“I thought that similar technology can be used to detect the SARS-CoV-2 virus, which is a folded protein,” Misra said. “This is Point of Care testing to assess the exposure to COVID-19. We do not need a laboratory setting or trained health care workers to administer the test. Electrochemical biosensors are advantageous for sensing purposes as they are sensitive, accurate and simple.”
The test does not require a blood sample, it is run using a nasal swab or even exhaled breath, which has biomarkers of COVID-19. Misra and his team have successfully demonstrated a simple, inexpensive, rapid and non-invasive diagnostic platform that has the potential to effectively detect the SARS-CoV-2 virus.
The team includes Associate Professor Subhash Verma, virologist, and Research Scientist Timsy Uppal at the University’s School of Medicine, and Misra’s post-doctoral researcher Bhaskar Vadlamani.
“Our role on this project is to provide viral material to be used for detection by the nanomaterial sensor developed by Mano,” Verma said. “Mano contacted me back in April or May and asked whether we can collaborate to develop a test to detect SARS-CoV-2 infection by analyzing patients’ breath. That’s where we came in, to provide biological material and started with providing the surface protein of the virus, which can be used for detecting the presence of the virus.”
Verma, an expert on SARS-CoV-2, synthesized and prepared the antigenic protein of COVID-19 virus in his laboratory, SARS-CoV-2 receptor binding domain protein, for the preliminary testing and determining the sensitivity of our nano sensor. Synthesizing and purification of viral proteins is usual and routine work in a virology laboratory.
“Our lab is a virology laboratory, which works on different viruses, and we have been working on SARS-CoV-2 from the beginning of the outbreak,” he said. “Our genomics and diagnostic group have been sequencing the SARS-CoV-2 from the nasal swabs of COVID-19 patients of the state of Nevada to determine mutational changes in the virus while SARS-CoV-2 circulates in our population.”
The team developed co-metal functionalized nanotubes as a sensing material for electrochemical detection of the protein. They confirmed the biosensor’s potential for clinical application by directly analyzing the RBD of the Spike glycoprotein on the sensor.
The team plans to move to the next step of sensor validation on the actual COVID-19 patients swabs stored in the Viral Transport Medium (VTM) and have applied for funding to develop a specific and inexpensive point-of-care sensor for a rapid detection of COVID-19 virus in saliva or breath of infected individuals.
“A rapid and accurate testing method is critical to establishing a rigorous testing protocol to allow us to continue our operations while maximizing the safety of our students, faculty and staff,” College of Engineering Dean Manos Maragakis said. “I am excited and proud that a research team led by faculty from the College of Engineering in collaboration with faculty from our Medical School are leading such a promising and innovative effort. I am looking forward to the outcome.”
The developed approach also has the potential for diagnosis of other respiratory viral diseases by identifying appropriate metallic elements to functionalize nanotubes.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Covid-19 detection
- Ruling: Iowa state auditor must provide more evidence to justify withholding emails
The state auditor's office must do more to justify its decision to withhold from public release emails between his office and two journalists, the Iowa Supreme Court ruled.
- Covid-19 Found in People’s Blood Months After Infection
A quarter of people had Covid-19 viral proteins in their blood up to 14 months after infection. These proteins in the blood indicate that SARS-CoV-2 keeps living in tissue reservoirs. The study used a ...
- Penn Medicine invests $28M in new weapons detection, security tools to limit violence against health workers
Physical and verbal violence against health care workers has reached record levels, according to federal data.
- Study suggests lingering coronavirus in tissues may contribute to long COVID symptoms
Study investigated whether SARS-CoV-2 lingers in tissues after COVID-19 recovery and if it's linked to long COVID symptoms. They found viral RNA in various organs, and its presence correlated with ...
- Protecting communities: The urgency of vaccinating to prevent a measles resurgence
The resurgence of measles and whooping cough is troubling. The most effective way to prevent the return and spread of vaccine-preventable diseases is through vaccination and combating vaccine ...
Go deeper with Google Headlines on:
Covid-19 detection
[google_news title=”” keyword=”Covid-19 detection” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
SARS-CoV-2 detection
- New tARC-seq method enhances precision in tracking SARS-CoV-2 mutations
The study highlighted tARC-seq, a specialized sequencing approach, to investigate the replication mistakes that influence SARS-CoV-2 divergence. This approach selectively reads specific RNA molecules ...
- COVID Shot Boosts Mucosal Immunity in Previously Infected People
COVID-19 mRNA vaccines stimulated mucosal immunity in people previously infected with SARS-CoV-2, but generated only a tiny amount of immunity in people who had never been infected, according to a ...
- Novel SARS-CoV-2 mutations found in floodwaters near homeless communities
Study: Environmental Surveillance of Flood Control Infrastructure Impacted by Unsheltered Individuals Leads to the Detection of SARS-CoV-2 and Novel Mutations in the Spike Gene. Image Credit ...
- Testing environmental water to monitor COVID-19 spread in unsheltered encampments
Using quantitative polymerase chain reaction, the researchers identified SARS-CoV-2 RNA in more than 25% of the samples tested from two flood-control channels. The highest detection frequency over ...
- Highly sensitive detection of SARS-CoV-2 by Crystal Digital PCR™
The current gold standard for COVID-19 diagnosis is based on the detection of SARS-CoV-2 nucleic acid using real-time quantitative PCR (RT-qPCR). Recent studies suggest limitations of RT-qPCR in the ...
Go deeper with Google Headlines on:
SARS-CoV-2 detection
[google_news title=”” keyword=”SARS-CoV-2 detection” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]